Class information for:
Level 1: GEMIFLOXACIN//CEFDITOREN//GEMIFLOXACIN MESYLATE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
3327 2008 32.0 76%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
233 3       JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLUOROQUINOLONES 48717
889 2             FLUOROQUINOLONES//QUINOLONES//CIPROFLOXACIN 11411
3327 1                   GEMIFLOXACIN//CEFDITOREN//GEMIFLOXACIN MESYLATE 2008

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GEMIFLOXACIN authKW 737263 4% 65% 75
2 CEFDITOREN authKW 310994 1% 68% 30
3 GEMIFLOXACIN MESYLATE authKW 258486 1% 100% 17
4 GARENOXACIN authKW 220983 1% 58% 25
5 FLUOROQUINOLONES authKW 217069 10% 7% 192
6 LEVOFLOXACIN authKW 192054 5% 11% 110
7 MUTANT PREVENTION CONCENTRATION authKW 171915 1% 54% 21
8 MUTANT SELECTION WINDOW authKW 162738 1% 63% 17
9 STREPTOCOCCUS PNEUMONIAE authKW 137625 9% 5% 184
10 MOXIFLOXACIN authKW 131451 4% 11% 78

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Infectious Diseases 47961 46% 0% 921
2 Microbiology 47269 63% 0% 1272
3 Pharmacology & Pharmacy 24459 63% 0% 1275
4 Immunology 188 7% 0% 131
5 Medicine, General & Internal 78 5% 0% 94
6 Oncology 63 5% 0% 104
7 Respiratory System 24 2% 0% 31
8 Toxicology 7 1% 0% 28
9 Critical Care Medicine 6 1% 0% 14
10 Primary Health Care 2 0% 0% 4

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MT AUBURN HOSP 68923 1% 19% 24
2 UNIDAD GENET BACTERIANA 68408 1% 38% 12
3 PATHOL CLIN MICROBIOL 61313 1% 37% 11
4 JMI S 51192 1% 21% 16
5 EIJKMAN WINKLER CLIN MICROBIOL 41383 0% 39% 7
6 GAUSE NEW ANTIBIOT 36351 1% 15% 16
7 JONES GRP 35987 1% 16% 15
8 DRUG EVALUAT DEV 30410 0% 100% 2
9 NOVABYSS INC 30410 0% 100% 2
10 SERV MALAD INFECT MICROBIOL MED MOL 30410 0% 100% 2

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 121610 22% 2% 434
2 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 94262 14% 2% 278
3 INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 73494 7% 4% 136
4 DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 46033 6% 2% 127
5 JOURNAL OF CHEMOTHERAPY 28333 3% 3% 68
6 CLINICAL MICROBIOLOGY AND INFECTION 8927 2% 1% 49
7 CHEMOTHERAPY 6881 2% 1% 34
8 CLINICAL INFECTIOUS DISEASES 6747 4% 1% 76
9 MICROBIAL DRUG RESISTANCE 2555 1% 1% 14
10 FORMULARY 2523 0% 2% 10

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 GEMIFLOXACIN 737263 4% 65% 75 Search GEMIFLOXACIN Search GEMIFLOXACIN
2 CEFDITOREN 310994 1% 68% 30 Search CEFDITOREN Search CEFDITOREN
3 GEMIFLOXACIN MESYLATE 258486 1% 100% 17 Search GEMIFLOXACIN+MESYLATE Search GEMIFLOXACIN+MESYLATE
4 GARENOXACIN 220983 1% 58% 25 Search GARENOXACIN Search GARENOXACIN
5 FLUOROQUINOLONES 217069 10% 7% 192 Search FLUOROQUINOLONES Search FLUOROQUINOLONES
6 LEVOFLOXACIN 192054 5% 11% 110 Search LEVOFLOXACIN Search LEVOFLOXACIN
7 MUTANT PREVENTION CONCENTRATION 171915 1% 54% 21 Search MUTANT+PREVENTION+CONCENTRATION Search MUTANT+PREVENTION+CONCENTRATION
8 MUTANT SELECTION WINDOW 162738 1% 63% 17 Search MUTANT+SELECTION+WINDOW Search MUTANT+SELECTION+WINDOW
9 STREPTOCOCCUS PNEUMONIAE 137625 9% 5% 184 Search STREPTOCOCCUS+PNEUMONIAE Search STREPTOCOCCUS+PNEUMONIAE
10 MOXIFLOXACIN 131451 4% 11% 78 Search MOXIFLOXACIN Search MOXIFLOXACIN

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 ZHANEL, GG , ENNIS, K , VERCAIGNE, L , WALKTY, A , GIN, AS , EMBIL, J , SMITH, H , HOBAN, DJ , (2002) A CRITICAL REVIEW OF THE FLUOROQUINOLONES - FOCUS ON RESPIRATORY TRACT INFECTIONS.DRUGS. VOL. 62. ISSUE 1. P. 13 -59 132 44% 166
2 BHAVNANI, SM , ANDES, DR , (2005) GEMIFLOXACIN FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS: IN VITRO SUSCEPTIBILITY, PHARMACOKINETICS AND PHARMACODYNAMICS, CLINICAL EFFICACY, AND SAFETY.PHARMACOTHERAPY. VOL. 25. ISSUE 5. P. 717 -740 83 69% 19
3 KEATING, GM , SCOTT, LJ , (2004) MOXIFLOXACIN - A REVIEW OF ITS USE IN THE MANAGEMENT OF BACTERIAL INFECTIONS.DRUGS. VOL. 64. ISSUE 20. P. 2347-2377 84 64% 44
4 LYNCH, JP , ZHANEL, GG , (2009) STREPTOCOCCUS PNEUMONIAE: DOES ANTIMICROBIAL RESISTANCE MATTER?.SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. VOL. 30. ISSUE 2. P. 210-238 124 34% 63
5 CHAVANET, P , CROISIER, D , (2006) MUTATION WINDOW FOR THE "PNEUMOCOCCUS-FLUOROQUINOLONE" COUPLE. CONTRIBUTION OF EXPERIMENTAL MODELS.MEDECINE ET MALADIES INFECTIEUSES. VOL. 36. ISSUE 11-12. P. 614-624 64 79% 2
6 BLONDEAU, JM , MISSAGHI, B , (2004) GEMIFLOXACIN: A NEW FLUOROQUINOLONE.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 5. ISSUE 5. P. 1117-1152 66 73% 11
7 VAN BAMBEKE, F , MICHOT, JM , VAN ELDERE, J , TULKENS, PM , (2005) QUINOLONES IN 2005: AN UPDATE.CLINICAL MICROBIOLOGY AND INFECTION. VOL. 11. ISSUE 4. P. 256 -280 93 37% 157
8 FERRARA, AM , (2005) NEW FLUOROQUINOLONES IN LOWER RESPIRATORY TRACT INFECTIONS AND EMERGING PATTERNS OF PNEUMOCOCCAL RESISTANCE.INFECTION. VOL. 33. ISSUE 3. P. 106 -114 54 76% 25
9 CROISIER, DE , ETIENNE, M , BERGOIN, E , CHARLES, PE , LEQUEU, C , PIROTH, L , PORTIER, H , CHAVANET, P , (2004) MUTANT SELECTION WINDOW IN LEVOFLOXACIN AND MOXIFLOXACIN TREATMENTS OF EXPERIMENTAL PNEUMOCOCCAL PNEUMONIA IN A RABBIT MODEL OF HUMAN THERAPY.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 48. ISSUE 5. P. 1699 -1707 51 77% 43
10 SCHENTAG, JJ , MEAGHER, AK , FORREST, A , (2003) FLUOROQUINOLONE AUIC BREAK POINTS AND THE LINK TO BACTERIAL KILLING RATES - PART 1: IN VITRO AND ANIMAL MODELS.ANNALS OF PHARMACOTHERAPY. VOL. 37. ISSUE 9. P. 1287 -1298 51 81% 32

Classes with closest relation at Level 1


Rank Class id link
1 6166 PENICILLIN RESISTANCE//STREPTOCOCCUS PNEUMONIAE//PENICILLIN RESISTANT PNEUMOCOCCI
2 6390 TELITHROMYCIN//KETOLIDE//MACROLIDE RESISTANCE
3 17251 BLNAR//PBP3//FTSI
4 15405 MARBOFLOXACIN//ENROFLOXACIN//DANOFLOXACIN
5 16319 POSTANTIBIOTIC EFFECT//POSTANTIBIOTIC SUB MIC EFFECT//POST ANTIBIOTIC EFFECT PAE
6 8152 BURNS TRAUMA CRIT CARE//MEROPENEM//AUGMENTED RENAL CLEARANCE
7 1143 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLEROXACIN
8 991 COMMUNITY ACQUIRED PNEUMONIA//PNEUMONIA//PNEUMONIA SEVERITY INDEX
9 14430 QNR//AAC6 IB CR//PLASMID MEDIATED QUINOLONE RESISTANCE
10 11697 N SUBSTITUTED PIPERAZINYL QUINOLONES//S ENOKI 3394//FLUOROQUINOLONES

Go to start page